Santhera gibt heute die Erweiterung seines exklusiven Vertriebsabkommens mit Biomedica f\u00fcr AGAMREE (Vamorolon) bekannt. Die Partnerschaft wird auf Georgien, Kasachstan, Belarus, Aserbaidschan und Usbekistan ausgeweitet und dient der Behandlung der Duchenne-Muskeldystrophie (DMD) bei Patienten ab zwei Jahren.<\/p>\n\n\n\n
Biomedica wurde urspr\u00fcnglich im Oktober 2025 zum Vertriebspartner f\u00fcr AGAMREE\u00ae ernannt. Im Rahmen der erweiterten Vereinbarung \u00fcbernimmt Biomedica den Vertrieb in f\u00fcnf weiteren M\u00e4rkten, w\u00e4hrend Santhera weiterhin einen prozentualen Anteil am Nettoumsatz gem\u00e4\u00df den Bedingungen der urspr\u00fcnglichen Vereinbarung erh\u00e4lt. In diesen zus\u00e4tzlichen L\u00e4ndern leben rund 2.000 Patienten mit Duchenne-Muskeldystrophie (DMD), deren Behandlungsm\u00f6glichkeiten sich bisher weitgehend auf Standard-Kortikosteroide beschr\u00e4nkten. Die erweiterte Vereinbarung erm\u00f6glicht es, AGAMREE\u00ae diesen Patienten zug\u00e4nglich zu machen. Weiterlesen: Was ist AGAMREE (Vamorolone)?<\/a><\/p>\n\n\n\n <\/p>","protected":false},"excerpt":{"rendered":" Santhera today announces an expansion of its exclusive distribution agreement with Biomedica for AGAMREE (vamorolone), extending the partnership to include Georgia, Kazakhstan, Belarus, Azerbaijan and Uzbekistan, for the treatment of Duchenne muscular dystrophy (DMD) in patients two years of age and older. Biomedica was originally appointed as a distributor for AGAMREE\u00ae in October 2025. Under […]<\/p>\n","protected":false},"author":1,"featured_media":8252,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[42,846,845,433,843,844,41,43],"class_list":["post-8251","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-agamree","tag-azerbaijan","tag-belarus","tag-biomedica","tag-georgia","tag-kazakhstan","tag-santhera","tag-vamorolone"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts\/8251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/comments?post=8251"}],"version-history":[{"count":1,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts\/8251\/revisions"}],"predecessor-version":[{"id":8253,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts\/8251\/revisions\/8253"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/media\/8252"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/media?parent=8251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/categories?post=8251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/tags?post=8251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}